110
edits
Difference between revisions of "Renal cell carcinoma grading"
Jump to navigation
Jump to search
m
reference to independent validation study
m (reference to independent validation study) |
|||
| Line 16: | Line 16: | ||
**Mostly based on [[nucleoli|nucleolar size]] and to a much lesser degree on size and morphology | **Mostly based on [[nucleoli|nucleolar size]] and to a much lesser degree on size and morphology | ||
**Developed based on ''Fuhrman grading''. | **Developed based on ''Fuhrman grading''. | ||
**Validated in other independent cohorts.<ref name=pmid28718911>{{Cite journal | last1 = Dagher | first1 = J. | last2 = Delahunt | first2 = B. | last3 = Rioux-Leclercq | first3 = N. | last4 = Egevad | first4 = L. | last5 = Srigley | first5 = JR. | last6 = Coughlin | first6 = G. | last7 = Dunglinson | first7 = N. | last8 = Gianduzzo | first8 = T. | last9 = Kua | first9 = B. | title = Clear cell renal cell carcinoma: validation of World Health Organization/International Society of Urological Pathology grading. | journal = Histopathology | volume = 71 | issue = 6 | pages = 918-925 | month = Dec | year = 2017 | doi = 10.1111/his.13311 | PMID = 28718911 }}</ref> | |||
** | |||
==ISUP grading== | ==ISUP grading== | ||